Coronavirus recovery drug approved for use in eczema - (This is Money via NewsPoints Desk)

  • Eli Lilly's baricitinib, which has been shown to cut recovery time from coronavirus when combined with remdesivir, has been approved as a once-a-day eczema treatment, as reported This is Money on Tuesday.

  • The drug, which will have the brand name Olumiant for treating eczema, is now available across Europe for adults with moderate to severe eczema.

  • Olumiant has yet to be approved for eczema use on the NHS by the National Institute for Health and Care Excellence, but people can obtain a private prescription.

To read more NewsPoints articles, click here.

Reference Articles